Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing

  • Scott D. Boyd
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA.
  • Eleanor L. Marshall
    Department of Genetics, Stanford University, Stanford, CA 94305, USA.
  • Jason D. Merker
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA.
  • Jay M. Maniar
    Department of Genetics, Stanford University, Stanford, CA 94305, USA.
  • Lyndon N. Zhang
    Department of Biology, Stanford University, Stanford, CA 94305, USA.
  • Bita Sahaf
    Department of Genetics, Stanford University, Stanford, CA 94305, USA.
  • Carol D. Jones
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA.
  • Birgitte B. Simen
    454 Life Sciences, A Roche Company, Branford, CT 06405, USA.
  • Bozena Hanczaruk
    454 Life Sciences, A Roche Company, Branford, CT 06405, USA.
  • Khoa D. Nguyen
    Department of Pediatrics-Allergy and Clinical Immunology, Stanford University, Stanford, CA 94305, USA.
  • Kari C. Nadeau
    Department of Pediatrics-Allergy and Clinical Immunology, Stanford University, Stanford, CA 94305, USA.
  • Michael Egholm
    454 Life Sciences, A Roche Company, Branford, CT 06405, USA.
  • David B. Miklos
    Department of Medicine, Stanford University, Stanford, CA 94305, USA.
  • James L. Zehnder
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA.
  • Andrew Z. Fire
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA.

説明

<jats:p>Massively parallel sequencing of rearranged immune receptor genes permits detection and tracking of specific immune cell populations in normal and pathological contexts.</jats:p>

収録刊行物

  • Science Translational Medicine

    Science Translational Medicine 1 (12), 12ra23-, 2009-12-23

    American Association for the Advancement of Science (AAAS)

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ